Mode
Text Size
Log in / Sign up
N/A Completed N=18 Randomized Double-blind Treatment

Phenolic-rich Oats and Artery Improvement

Healthy
Source: ClinicalTrials.gov NCT02731755 ↗
Enrolled (actual)
18
Serious AEs
0.0%
Results posted
Nov 2019
Primary outcomePrimary: Flow Mediated Dilatation — 4.4; 3.9; 3.4; 4.4 metre — p=0.5

Summary

In this proposed human trial, the investigators aim to establish whether consumption of one portion of phenolic acid-rich oats leads to acute improvements (i.e. 1-24h post-intake) in markers of cardiovascular disease risk relative to an energy matched control intervention in healthy men with high-normal to mildly elevated blood pressure.

Outcome Measures

OutcomeResultp-value
PRIMARY
Flow Mediated Dilatation
4.4; 3.9; 3.4; 4.4; 4.4; 3.6 0.5
SECONDARY
Laser Doppler Iontophoresis
538.2; 465; 681.8; 463.7; 381.3; 315 0.04 sig
SECONDARY
Phenolic Acids Metabolites - Ferulic Acid
10.6; 0.4; 33.9; 9; 153.5; 10.3 0.9
SECONDARY
Plasma Nitric Oxide Analysis
— —
SECONDARY
NADPH Oxidase Activity in Neutrophil Blood Cells
55.7; 58.6; 43.6; 47.9; 63.6; 61.6 0.7
SECONDARY
Plasma Glucose
— —
SECONDARY
Plasma Insulin
— —
SECONDARY
Renin Activity
— —

Eligibility Criteria

Inclusion Criteria

  • Above average blood pressure (i.e. systolic 120-159 mmHg and diastolic 75-99 mmHg)

Exclusion Criteria

  • Abnormal biochemical, haematological results as assessed at health screening
  • Hypertension (i.e. systolic/diastolic blood pressure ≥160/100 mm Hg) BMI >35
  • Current smoker or ex-smoker ceasing 3 x 20 min aerobic exercise/week)
  • Consumption of ≥21 units of alcohol/week
  • Small veins not allowing cannulation
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02731755). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search